96 related articles for article (PubMed ID: 3054417)
1. Systemic mast cell disease. Analysis of 58 cases and literature review.
Travis WD; Li CY; Bergstralh EJ; Yam LT; Swee RG
Medicine (Baltimore); 1988 Nov; 67(6):345-68. PubMed ID: 3054417
[TBL] [Abstract][Full Text] [Related]
2. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.
Lawrence JB; Friedman BS; Travis WD; Chinchilli VM; Metcalfe DD; Gralnick HR
Am J Med; 1991 Dec; 91(6):612-24. PubMed ID: 1750431
[TBL] [Abstract][Full Text] [Related]
3. Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis.
Horny HP; Ruck P; Kröber S; Kaiserling E
Histol Histopathol; 1997 Oct; 12(4):1081-9. PubMed ID: 9302569
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease.
Stevens EC; Rosenthal NS
Am J Clin Pathol; 2001 Aug; 116(2):177-82. PubMed ID: 11488063
[TBL] [Abstract][Full Text] [Related]
5. Splenectomy in the management of systemic mast cell disease.
Friedman B; Darling G; Norton J; Hamby L; Metcalfe D
Surgery; 1990 Jan; 107(1):94-100. PubMed ID: 2404352
[TBL] [Abstract][Full Text] [Related]
6. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
7. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
8. Solid and hematologic malignancies in 60 patients with systemic mast cell disease.
Travis WD; Li CY; Bergstralh EJ
Arch Pathol Lab Med; 1989 Apr; 113(4):365-8. PubMed ID: 2650653
[TBL] [Abstract][Full Text] [Related]
9. [Systemic mastocytosis and secondary acute myeloid leukemia].
Galán Alvarez P; Ibáñez García J; Funes Vera C; López García-Carreño MD; Alix Trueba A; Pérez Guillermo M; Alberola C
An Med Interna; 1999 Sep; 16(9):466-8. PubMed ID: 10609361
[TBL] [Abstract][Full Text] [Related]
10. [Systemic mastocytosis. A review of current diagnostic and therapeutic approaches].
Pari F; Zamagni MD; Carnevali C; Pagani M; Rabbi C; Cantore M; Cavazzini G; Aitini E; Smerieri F
Recenti Prog Med; 1999 Mar; 90(3):169-72. PubMed ID: 10228358
[TBL] [Abstract][Full Text] [Related]
11. Pathology of the lymph node and spleen in systemic mast cell disease.
Travis WD; Li CY
Mod Pathol; 1988 Jan; 1(1):4-14. PubMed ID: 3237690
[TBL] [Abstract][Full Text] [Related]
12. Systemic mast cell disease associated with the hypereosinophilic syndrome.
McElroy EA; Phyliky RL; Li CY
Mayo Clin Proc; 1998 Jan; 73(1):47-50. PubMed ID: 9443678
[TBL] [Abstract][Full Text] [Related]
13. The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival.
Varki A; Lottenberg R; Griffith R; Reinhard E
Medicine (Baltimore); 1983 Nov; 62(6):353-71. PubMed ID: 6633248
[TBL] [Abstract][Full Text] [Related]
14. [Systemic mastocytosis. Study of 14 cases].
García-Erce JA; Giraldo P; de Vicente P; Alvarez R; Losfablos F; Velilla J; Mayayo P; Rubio-Félix D; Giralt M
Med Clin (Barc); 1998 Oct; 111(13):499-502. PubMed ID: 9859067
[TBL] [Abstract][Full Text] [Related]
15. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
Valent P; Sperr WR; Schwartz LB; Horny HP
J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
[TBL] [Abstract][Full Text] [Related]
17. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors.
Caballero MD; Rubio V; Rifon J; Heras I; García-Sanz R; Vázquez L; Vidriales B; del Cañizo MC; Corral M; Gonzalez M; León A; Jean-Paul E; Rocha E; Moraleda JM; San Miguel JF
Bone Marrow Transplant; 1997 Sep; 20(6):451-8. PubMed ID: 9313877
[TBL] [Abstract][Full Text] [Related]
18. Significance of systemic mast cell disease with associated hematologic disorders.
Travis WD; Li CY; Yam LT; Bergstralh EJ; Swee RG
Cancer; 1988 Sep; 62(5):965-72. PubMed ID: 3409177
[TBL] [Abstract][Full Text] [Related]
19. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
20. [Mastocytosis, classification, biological diagnosis and therapy].
Arock M
Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
